Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis
Alabed, I.B.; Qushmaq, K.A.; Khan, M.A.
Saudi Medical Journal 31(9): 1054-1056
2010
ISSN/ISBN: 0379-5284 PMID: 20844821 Document Number: 639438
Although the therapeutic uses of tumor necrosis factor alpha antagonists have added a highly effective treatment of ankylosing spondylitis and associated spondyloarthropathies, they are associated with many untoward effects. We describe a Saudi patient with ankylosing spondylitis who developed severe psoriatic lesions in treatment with infliximab. He had no personal, or family history of psoriasis, and no other triggering factors known to induce psoriasis.
Document emailed within 1 workday
Related Documents
Famenini, S.; Wu, J.J. 2013: Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases Journal of Drugs in Dermatology: Jdd 12(8): 939-943Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Sanli, H.; Ataman, S.; Akay, B.ü N.; Yilmaz, A.; Yildizlar, D.; Gürgey, E. 2007: Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy Journal of Drugs in Dermatology: Jdd 6(8): 834-836
Brandt, J.; Sieper, J.; Braun, J. 2002: Infliximab in the treatment of active and severe ankylosing spondylitis Clinical and Experimental Rheumatology 20(6 Suppl 28: S106-S110
Stone, M.; Salonen, D.; Lax, M.; Payne, U.; Lapp, V.; Inman, R. 2001: Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis Journal of Rheumatology 28(7): 1605-1614
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Kiortsis, D.N.; Mavridis, A.K.; Filippatos, T.D.; Vasakos, S.; Nikas, S.N.; Drosos, A.A. 2006: Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 33(5): 921-923
Haibel, H.; Song, I.H.; Rudwaleit, M.; Listing, J.; Hildemann, S.; Sieper, J. 2008: Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice Clinical and Experimental Rheumatology 26(2): 247-252
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Brophy, S.; Taylor, G.; Blake, D.; Calin, A. 2003: The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis Journal of Rheumatology 30(9): 2054-2058
Thurber, M.; Feasel, A.; Stroehlein, J.; Hymes, S.R. 2004: Pustular psoriasis induced by infliximab Journal of Drugs in Dermatology: Jdd 3(4): 439-440
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Krishnan, R.S.; Hsu, S. 2004: Serum sickness due to infliximab in a patient with psoriasis Journal of Drugs in Dermatology: Jdd 3(3): 305-308
Furst, S.R.; Kindynis, P.; Gundry, C.; Haghighi, P.; Sartoris, D.J.; Resnick, D. 1990: Pseudopseudarthrosis in a patient with ankylosing spondylitis Journal of Rheumatology 17(2): 258-262
Haywood, K.L.; Garratt, A.M.; Dziedzic, K.; Dawes, P.T. 2003: Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index Journal of Rheumatology 30(4): 764-773
Reis, E.; Carvalho, J. 2013: Onset of rheumatoid arthritis in a patient with ankylosing spondylitis Acta Reumatologica Portuguesa 38(3): 217-219
Retief, J.H.; Rossouw, D.S.; Theron, M.H.; Swanepoel, H.M. 1988: Dilated cardiomyopathy in a patient with ankylosing spondylitis. A case report South African Medical Journal 74(5): 238-240
Oh, D.H.; Jun, J.B.; Kim, H.T.; Lee, S.W.; Jung, S.S.; Lee, I.H.; Kim, S.Y. 2001: Transverse myelitis in a patient with long-standing ankylosing spondylitis Clinical and Experimental Rheumatology 19(2): 195-196